Futura Medical (FUM) Share Price, News & Analysis

Company Overview

Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.

Key Stats

• Today's Range: 9.02 to 10
• 50-Day Range: 7.20 to 13.41
• 52-Week Range: 7 to 45.56
• Volume: 181,110 shs
• Average Volume: 660,163 shs
• Market Capitalization: £27.41 million
• P/E Ratio: 2,200.00
• Dividend Yield: 4.55%
• Price Target: N/A
• Consensus Rating: N/A

FUM Stock Analysis - Frequently Asked Questions

How have FUM shares performed this year?

Futura Medical's stock was trading at GBX 31.67 on January 1st, 2025. Since then, FUM shares have decreased by 71.5% and is now trading at GBX 9.02.

How were Futura Medical's earnings last quarter?

Futura Medical plc (LON:FUM) issued its quarterly earnings results on Tuesday, April, 15th. The company reported $0.43 EPS for the quarter. Futura Medical had a negative trailing twelve-month return on equity of 56.44% and a negative net margin of 44.64%.

How do I buy shares of Futura Medical?

Shares of FUM stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Futura Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Futura Medical investors own include Indivior (INDV), Tullow Oil (TLW), Lloyds Banking Group (LLOY), Bigblu Broadband (BBB), BP (BP), Directa Plus (DCTA) and Genel Energy (GENL).

Company Calendar

• Last Earnings: 4/15/2025
• Today: 9/02/2025

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: LON:FUM
• CIK: N/A
• Web: www.futuramedical.com
• Phone: +44-1483-685670
• Fax: N/A
• Employees: 12
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): GBX 0
• Trailing P/E Ratio: 2,200.00
• Forward P/E Ratio: 3.17
• P/E Growth: N/A
• Net Income: -£3.88 million
• Net Margins: -44.64%
• Pretax Margin: N/A
• Return on Equity: -56.44%
• Return on Assets: -26.59%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 3.75
• Quick Ratio: 5.73

Sales & Book Value

• Annual Sales: £13.93 million
• Price / Sales: 1.97
• Cash Flow: GBX 0.44 per share
• Price / Cash Flow: 20.43
• Book Value: GBX 2.59 per share
• Price / Book: 3.48

Miscellaneous

• Outstanding Shares: 303,830,000
• Free Float: N/A
• Market Cap: £27.41 million
• Optionable: Not Optionable
• Beta: 1.25